| 1 | Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Cancer Cell | 2010 | 5,542 |
| 2 | Tensional homeostasis and the malignant phenotype | Cancer Cell | 2005 | 2,916 |
| 3 | Integrative Genomic Profiling of Human Prostate Cancer | Cancer Cell | 2010 | 2,871 |
| 4 | Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN | Cancer Cell | 2009 | 2,621 |
| 5 | The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth | Cancer Cell | 2023 | 2,497 |
| 6 | A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Cancer Cell | 2006 | 2,379 |
| 7 | Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Cancer Cell | 2006 | 2,323 |
| 8 | Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Cancer Cell | 2006 | 2,316 |
| 9 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Cancer Cell | 2005 | 2,247 |
| 10 | Defining the Role of mTOR in Cancer | Cancer Cell | 2007 | 2,228 |
| 11 | Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases | Cancer Cell | 2011 | 2,196 |
| 12 | Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation | Cancer Cell | 2010 | 2,061 |
| 13 | Targeting Ferroptosis to Iron Out Cancer | Cancer Cell | 2019 | 1,963 |
| 14 | Oxidative Stress in Cancer | Cancer Cell | 2020 | 1,960 |
| 15 | Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival | Cancer Cell | 2014 | 1,952 |
| 16 | Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice | Cancer Cell | 2005 | 1,895 |
| 17 | Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Cancer Cell | 2003 | 1,829 |
| 18 | A multigenic program mediating breast cancer metastasis to bone | Cancer Cell | 2003 | 1,825 |
| 19 | Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis | Cancer Cell | 2009 | 1,793 |
| 20 | Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma | Cancer Cell | 2010 | 1,777 |
| 21 | Tumor Cell Metabolism: Cancer's Achilles' Heel | Cancer Cell | 2008 | 1,773 |
| 22 | Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Cancer Cell | 2006 | 1,768 |
| 23 | IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer | Cancer Cell | 2009 | 1,765 |
| 24 | Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma | Cancer Cell | 2012 | 1,636 |
| 25 | Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase | Cancer Cell | 2005 | 1,630 |
| 26 | Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma | Cancer Cell | 2014 | 1,582 |
| 27 | Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis | Cancer Cell | 2006 | 1,576 |
| 28 | A Perivascular Niche for Brain Tumor Stem Cells | Cancer Cell | 2007 | 1,556 |
| 29 | The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate | Cancer Cell | 2010 | 1,554 |
| 30 | YAP/TAZ at the Roots of Cancer | Cancer Cell | 2016 | 1,513 |
| 31 | Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis | Cancer Cell | 2011 | 1,441 |
| 32 | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma | Cancer Cell | 2017 | 1,421 |
| 33 | Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma | Cancer Cell | 2012 | 1,392 |
| 34 | Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment | Cancer Cell | 2017 | 1,371 |
| 35 | Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy | Cancer Cell | 2014 | 1,322 |
| 36 | NRF2 and the Hallmarks of Cancer | Cancer Cell | 2018 | 1,313 |
| 37 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients | Cancer Cell | 2004 | 1,302 |
| 38 | Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance | Cancer Cell | 2006 | 1,280 |
| 39 | A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma | Cancer Cell | 2014 | 1,279 |
| 40 | AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients | Cancer Cell | 2007 | 1,273 |
| 41 | Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer | Cancer Cell | 2018 | 1,263 |
| 42 | Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | Cancer Cell | 2002 | 1,238 |
| 43 | Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics | Cancer Cell | 2002 | 1,233 |
| 44 | Nuclear factor-κB | Cancer Cell | 2004 | 1,227 |
| 45 | Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors | Cancer Cell | 2005 | 1,211 |
| 46 | Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis | Cancer Cell | 2014 | 1,210 |
| 47 | Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia | Cancer Cell | 2002 | 1,208 |
| 48 | Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner | Cancer Cell | 2010 | 1,204 |
| 49 | A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth | Cancer Cell | 2007 | 1,191 |
| 50 | Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis | Cancer Cell | 2014 | 1,186 |